Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm
Clinical trial NCT06219915 · COMPLETED
Trial details
- NCT number
- NCT06219915
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2024-05-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.